EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior

Lena Gaugler iD, Sebastian Hofmann, Michael Schlüter, Ralf Takors iD

Biotechnology and Bioengineering · 2024-04 · 121 (4) · 1243-1255

DOI: 10.1002/bit.28647 ↗

At a glance

Journal article in Biotechnology and Bioengineering, published online on 2024-01-08. Written by Lena Gaugler and 3 co-authors. Institution: Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany. Major MEDLINE topics: Batch Cell Culture Techniques, Bioreactors. Cited 14 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: Deutsche Forschungsgemeinschaft, German Research Foundation (DFG).

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

During the scale‐up of biopharmaceutical production processes, insufficiently predictable performance losses may occur alongside gradients and heterogeneities. To overcome such performance losses, tools are required to explain, predict, and ultimately prohibit inconsistencies between laboratory and commercial scale. In this work, we performed CHO fed‐batch cultivations in the single multicompartment bioreactor (SMCB), a new scale‐down reactor system that offers new access to study large‐scale heterogeneities in mammalian cell cultures. At volumetric power inputs of 20.4–1.5 W m −3 , large‐scale characteristics like long mixing times and dissolved oxygen (DO) heterogeneities were mimicked in the SMCB. Compared to a reference bioreactor (REFB) set‐up, the conditions in the SMCB provoked an increase in lactate accumulation of up to 87%, an increased glucose uptake, and reduced viable cell concentrations in the stationary phase. All are characteristic for large‐scale performance. The unique possibility to distinguish between the effects of changing power inputs and observed heterogeneities provided new insights into the potential reasons for altered product quality attributes. Apparently, the degree of galactosylation in the evaluated glycan patterns changed primarily due to the different power inputs rather than the provoked heterogeneities. The SMCB system could serve as a potent tool to provide new insights into scale‐up behavior and to predict cell line‐specific drawbacks at an early stage of process development.

Subjects

MeSH terms (MEDLINE)

Batch Cell Culture TechniquesBioreactorsAnimalsCricetinaeCell LineCHO CellsCricetulusOxygen

Author keywords

CHO fed‐batch cultivationsSMCBgradientslarge‐scale heterogeneitiesmulticompartment systemscale‐down

Substances

Oxygen

Authors and institutions

  • Institute of Biochemical Engineering, University of Stuttgart, Stuttgart, Germany.
  • Institute of Multiphase Flows, Hamburg University of Technology, Hamburg, Germany.

ORCID profiles: Lena Gaugler, Ralf Takors

Funding

  • Deutsche Forschungsgemeinschaft
  • German Research Foundation (DFG)

Cite

APA

Gaugler, L., Hofmann, S., Schlüter, M., & Takors, R. (2024). Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior. Biotechnology and Bioengineering, 121(4), 1243-1255. https://doi.org/10.1002/bit.28647

Vancouver

Gaugler L, Hofmann S, Schlüter M, Takors R. Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior. Biotechnology and Bioengineering. 2024;121(4):1243-1255. doi:10.1002/bit.28647

BibTeX
@article{Gaugler2024,
  author = {Gaugler, Lena and Hofmann, Sebastian and Schlüter, Michael and Takors, Ralf},
  title = {Mimicking CHO large‐scale effects in the single multicompartment bioreactor: A new approach to access scale‐up behavior},
  journal = {Biotechnology and Bioengineering},
  year = {2024},
  volume = {121},
  number = {4},
  pages = {1243--1255},
  doi = {10.1002/bit.28647}
}
Start for free →